Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hiroki Yokoyama
Institutions:
Jikei University School of Medicine,
The Jikei University Hospital
Observed institutions:
Jikei University School of Medicine,
The Jikei University Hospital
ORCID:
0009-0002-6712-9012
Observed ORCID:
0009-0002-6712-9012
OpenAlex ID:
A5122105289
Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE ‐ STOP219 study
2026
·
Noriyoshi Iriyama
, Naoto Takahashi
, et al.
·
British Journal of Haematology
·
3
Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma
2026
·
Kazuhito Suzuki
, Tadahiro Gunji
, et al.
·
International Journal of Clinical Oncology
·
1
Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotype
2026
·
Hiroki Yokoyama
, Masamitsu Yanada
, et al.
·
International Journal of Hematology
·
1
[Aplastic anemia developed after treatment with durvalumab].
2026
·
Kaho Maeshima
, Yo Sakayori
, et al.
·
PubMed
·
1
Show more works
View as search
Works count:
4
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type